Seeing Is Believing
Healthcare - Sector
CRL is currently covered by 14 analysts with an average price target of $242.13. This is a potential upside of $26.62 (12.35%) from yesterday's end of day stock price of $215.51.
Charles River Laboratories's activity chart (see below) currently has 333 price targets and 230 ratings on display. The stock rating distribution of CRL is 74.29% HOLD and 25.71% BUY.
Analysts average stock forecasts to be materialized ratio is 70.28% with an average time for these price targets to be met of 92.79 days.
Highest price target for CRL is $215, Lowest price target is $150, average price target is $186.92.
Most recent stock forecast was given by ANN HYNES from MIZUHO on 18-Dec-2025. First documented stock forecast 30-Oct-2014.
Currently out of the existing stock ratings of CRL, 26 are a HOLD (74.29%), 9 are a BUY (25.71%).
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 07-Jun-2024
$200
$-2.42 (-1.20%)
$174
22 days ago
(18-Dec-2025)
6/6 (100%)
$6.15 (3.17%)
44
Buy
Since 02-Oct-2025
$215
$12.58 (6.21%)
$210
25 days ago
(15-Dec-2025)
7/9 (77.78%)
$21.97 (11.38%)
50
Hold
Since 08-Aug-2024
$190
$-12.42 (-6.14%)
$160
25 days ago
(15-Dec-2025)
4/5 (80%)
$-3.03 (-1.57%)
17
Hold
Since 28-Jun-2024
1 months 23 days ago
(17-Nov-2025)
5/7 (71.43%)
$27.87 (10.63%)
136
Buy
Since 10-Nov-2025
$197
$-5.42 (-2.68%)
$105
1 months 30 days ago
(10-Nov-2025)
8/9 (88.89%)
$28.03 (16.59%)
91
What is CRL (Charles River Laboratories) average time for price targets to be met?
Which analyst has the current highest performing score on CRL (Charles River Laboratories) with a proven track record?
Which analyst has the most public recommendations on CRL (Charles River Laboratories)?
Which analyst is the currently most bullish on CRL (Charles River Laboratories)?
Which analyst is the currently most reserved on CRL (Charles River Laboratories)?